The risk may not be worth the reward, but it's worth the experience.

Vital lives are about action. You can't feel warmth unless you create it, can't feel delight until you play, can't know serendipity unless you risk.

It is possible that pharmaceutical group stock momentum could carry (Lilly) higher, but we believe the risk/reward warrants a neutral rating.

It's too much risk for too little reward.

At some point in time, one has to ask themselves, is this all the world has to offer me?

With payrolls so close, people are looking at risk/reward and deciding to be safe.